Literature DB >> 3108455

Effects of methylprednisolone and the combination of alpha-tocopherol and selenium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue.

R D Saunders, L L Dugan, P Demediuk, E D Means, L A Horrocks, D K Anderson.   

Abstract

Traumatic injury of the spinal cord leads to a series of pathological events that result in tissue necrosis and paralysis. Among the earliest biochemical reactions are hydrolysis of fatty acids from membrane phospholipids, production of biologically active eicosanoids, and peroxidation of lipids. This study examines the effect of agents purported to improve recovery following spinal cord trauma, methylprednisolone sodium succinate (MPSS) and the combination of alpha-tocopherol and selenium (Se), on the posttraumatic alterations of membrane lipid metabolism. Pretreatment with either MPSS or alpha-tocopherol and Se reduced the trauma-induced release of total FFA including arachidonate in the injured spinal cord tissue. In addition, these agents decreased the postinjury levels of prostanoids. Pretreatment with either MPSS or alpha-tocopherol and Se also completely prevented the trauma-induced loss of cholesterol while inhibiting the increase of a cholesterol peroxidation product, 25-hydroxycholesterol. These data suggest that: perturbation of membrane lipid metabolism may contribute to the tissue necrosis and functional deficit of spinal cord injury and MPSS or the combination of alpha-tocopherol and Se may protect injured spinal cord tissue, at least in part, by limiting these posttraumatic membrane lipid changes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3108455     DOI: 10.1111/j.1471-4159.1987.tb03388.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  19 in total

Review 1.  Medical treatments of acute spinal cord injury.

Authors:  W Young
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

2.  The effects of chronic alpha-tocopherol administration on lipid peroxidation in an experimental model of acute spinal cord injury.

Authors:  M Bozbuğa; N Izgi; A Canbolat
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

Review 3.  The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.

Authors:  Fernando Scaglia; Jennifer L Northrop
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 4.  Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice.

Authors:  J Lan; D H Jiang
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

5.  Redox changes in perfusates following intracerebral penetration of microdialysis probes.

Authors:  M E Layton; J K Wagner; F E Samson; T L Pazdernik
Journal:  Neurochem Res       Date:  1997-06       Impact factor: 3.996

6.  Neuroprotective effects of ebselen on experimental spinal cord injury in rats.

Authors:  Murat Kalayci; Omer Coskun; Ferda Cagavi; Mehmet Kanter; Ferah Armutcu; Sanser Gul; Bektas Acikgoz
Journal:  Neurochem Res       Date:  2005-03       Impact factor: 3.996

7.  Neuroprotective effect of methylprednisolone combined with placenta-derived mesenchymal stem cell in rabbit model of spinal cord injury.

Authors:  Jiang-Wei Tan; Kai-Yan Wang; Guang-Jun Liao; Fang-Min Chen; Ming-Zhang Mu
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

8.  Model of Traumatic Spinal Cord Injury for Evaluating Pharmacologic Treatments in Cynomolgus Macaques (Macaca fasicularis).

Authors:  Nitin Seth; Heather A Simmons; Farah Masood; William A Graham; Douglas L Rosene; Susan V Westmoreland; Sheila M Cummings; Basia Gwardjan; Ervin Sejdic; Amber F Hoggatt; Dane R Schalk; Hussein A Abdullah; John B Sledge; Shanker Nesathurai
Journal:  Comp Med       Date:  2018-02-01       Impact factor: 0.982

9.  Neuroprotective role of hydralazine in rat spinal cord injury-attenuation of acrolein-mediated damage.

Authors:  Jonghyuck Park; Lingxing Zheng; Andrew Marquis; Michael Walls; Brad Duerstock; Amber Pond; Sasha Vega-Alvarez; He Wang; Zheng Ouyang; Riyi Shi
Journal:  J Neurochem       Date:  2013-12-15       Impact factor: 5.372

10.  Effects of mexiletine, ginkgo biloba extract (EGb 761), and their combination on experimental head injury.

Authors:  Ahmet Menkü; R Kemal Koç; Vatan Tayfur; Recep Saraymen; Figen Narin; Hidayet Akdemir
Journal:  Neurosurg Rev       Date:  2003-07-12       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.